A data-driven pipeline to extract potential side effects through co-prescription analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up

P. Sabatier, M. Wack, J. Pouchot, N. Danchin, AS. Jannot
doi: https://doi.org/10.1101/2021.04.14.21255406

Article Information

doi 
https://doi.org/10.1101/2021.04.14.21255406
History 
  • April 20, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. P. Sabatier1,2,*,
  2. M. Wack1,2,
  3. J. Pouchot3,
  4. N. Danchin4 and
  5. AS. Jannot1,2
  1. 1Medical Information Department, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France
  2. 2INSERM U1138, University Paris Descartes, Sorbonne University, 75006 Paris, France
  3. 3Department of Internal Medicine, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France
  4. 4Department of Cardiology, Georges Pompidou European Hospital, AP-HP, 75015 Paris, France; University Paris-Descartes, 75006 Paris, France
  1. ↵*Corresponding author: Pierre Sabatier, pierre.sabatier{at}aphp.fr, 20 Rue Leblanc, 75015 Paris, France, Tel: (+33) 638 689 717
Back to top
Posted April 20, 2021.
Download PDF
Data/Code
Email
A data-driven pipeline to extract potential side effects through co-prescription analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up
P. Sabatier, M. Wack, J. Pouchot, N. Danchin, AS. Jannot
medRxiv 2021.04.14.21255406; doi: https://doi.org/10.1101/2021.04.14.21255406
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area